ArticleMedical oncology (Northwood, London, England)2024

Combination of navitoclax (Bcl-2 and Bcl-xL inhibitor) and Debio-0932 (Hsp90 inhibitor) suppresses the viability of prostate cancer cells via induction of apoptotic signaling pathway.

Aydemir Asdemir et al.PubMed ↗Publisher ↗

No numbers read from the abstract.